Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 189

    1.

    Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems.

    Laitala-Leinonen T.

    J Negat Results Biomed. 2005 Aug 29;4:5.

    PMID:
    16124882
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    PPAR agonists modulate human osteoclast formation and activity in vitro.

    Chan BY, Gartland A, Wilson PJ, Buckley KA, Dillon JP, Fraser WD, Gallagher JA.

    Bone. 2007 Jan;40(1):149-59. Epub 2006 Sep 28.

    PMID:
    17010686
    [PubMed - indexed for MEDLINE]
    4.

    GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

    Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J.

    J Immunol. 2009 Sep 1;183(5):3390-9. Epub 2009 Jul 29.

    PMID:
    19641137
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Osteoclast formation and bone resorption are inhibited by megakaryocytes.

    Beeton CA, Bord S, Ireland D, Compston JE.

    Bone. 2006 Nov;39(5):985-90. Epub 2006 Jul 25.

    PMID:
    16870519
    [PubMed - indexed for MEDLINE]
    6.

    DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.

    Lorenzo JA, Raisz LG, Hock JM.

    J Clin Invest. 1983 Dec;72(6):1924-9.

    PMID:
    6643680
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.

    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.

    J Cell Physiol. 2009 Dec;221(3):618-28.

    PMID:
    19653230
    [PubMed - indexed for MEDLINE]
    8.

    Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes.

    Gallois A, Lachuer J, Yvert G, Wierinckx A, Brunet F, Rabourdin-Combe C, Delprat C, Jurdic P, Mazzorana M.

    J Bone Miner Res. 2010 Mar;25(3):661-72.

    PMID:
    19775202
    [PubMed - indexed for MEDLINE]
    9.

    Development of a monoclonal antibody to osteoclasts formed in vitro which recognizes mononuclear osteoclast precursors in the marrow.

    Kukita T, Roodman GD.

    Endocrinology. 1989 Aug;125(2):630-7.

    PMID:
    2752970
    [PubMed - indexed for MEDLINE]
    10.

    Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.

    Olivier BJ, Schoenmaker T, Mebius RE, Everts V, Mulder CJ, van Nieuwkerk KM, de Vries TJ, van der Merwe SW.

    Hepatology. 2008 Jan;47(1):259-67.

    PMID:
    18022900
    [PubMed - indexed for MEDLINE]
    11.

    Role of cell-matrix interactions in osteoclast differentiation.

    McHugh KP, Shen Z, Crotti TN, Flannery MR, Fajardo R, Bierbaum BE, Goldring SR.

    Adv Exp Med Biol. 2007;602:107-11.

    PMID:
    17966395
    [PubMed - indexed for MEDLINE]
    12.

    A novel method for efficient generation of transfected human osteoclasts.

    Taylor A, Rogers MJ, Tosh D, Coxon FP.

    Calcif Tissue Int. 2007 Feb;80(2):132-6. Epub 2007 Feb 3.

    PMID:
    17308995
    [PubMed - indexed for MEDLINE]
    13.

    Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.

    El Hajj Dib I, Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.

    Eur J Pharmacol. 2006 Dec 3;551(1-3):27-33. Epub 2006 Sep 16.

    PMID:
    17049513
    [PubMed - indexed for MEDLINE]
    14.

    Osteoclast formation from mononuclear phagocytes: role of bone-forming cells.

    Burger EH, van der Meer JW, Nijweide PJ.

    J Cell Biol. 1984 Dec;99(6):1901-6.

    PMID:
    6501407
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Complex dynamics of osteoclast formation and death in long-term cultures.

    Akchurin T, Aissiou T, Kemeny N, Prosk E, Nigam N, Komarova SV.

    PLoS One. 2008 May 7;3(5):e2104.

    PMID:
    18461134
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Osteoclasts direct bystander killing of cancer cells in vitro.

    Ramnaraine M, Pan W, Clohisy DR.

    Bone. 2006 Jan;38(1):4-12. Epub 2005 Sep 1.

    PMID:
    16139579
    [PubMed - indexed for MEDLINE]
    17.

    Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells.

    Dalbeth N, Smith T, Nicolson B, Clark B, Callon K, Naot D, Haskard DO, McQueen FM, Reid IR, Cornish J.

    Arthritis Rheum. 2008 Jun;58(6):1854-65.

    PMID:
    18512794
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners.

    Takahashi M, Mizoguchi T, Uehara S, Nakamichi Y, Yang S, Naramoto H, Yamashita T, Kobayashi Y, Yamaoka M, Furusawa K, Udagawa N, Uematsu T, Takahashi N.

    J Bone Miner Metab. 2009;27(1):24-35. Epub 2008 Dec 13.

    PMID:
    19082914
    [PubMed - indexed for MEDLINE]
    19.

    Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

    Michael H, Härkönen PL, Kangas L, Väänänen HK, Hentunen TA.

    Br J Pharmacol. 2007 Jun;151(3):384-95. Epub 2007 Apr 10.

    PMID:
    17420779
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis.

    Kakehi S, Nakahama K, Morita I.

    Mol Cell Biochem. 2007 Jul;301(1-2):209-17. Epub 2007 Feb 8.

    PMID:
    17286202
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk